Patient Advocacy Groups Ask Congress to Leave Medicare Prescription Drug Benefit Alone

The National Patient Advocate Foundation (NPAF) has joined more than 200 patient advocacy groups, physicians' organizations, and business and labor leaders from across the country in urging Congress to reject proposals to impose a Medicaid-style rebate system onto the Medicare Part D prescription drug program.